Us Bancorp \De\ Axonics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Axonics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 223 shares of AXNX stock, worth $15,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223

Previous 426 47.65%

Holding current value

$15,828

Previous $28,000 46.43%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$67.3 - $69.67 $13,661 - $14,143	-203 Reduced 47.65%	223 $15,000
Q2 2024 Aug 06, 2024	SELL	$66.47 - $69.65 $2,991 - $3,134	-45 Reduced 9.55%	426 $28,000
Q1 2024 May 07, 2024	SELL	$56.67 - $69.36 $53,893 - $65,961	-951 Reduced 66.88%	471 $32,000
Q4 2023 Feb 09, 2024	SELL	$49.38 - $63.75 $1,036 - $1,338	-21 Reduced 1.46%	1,422 $88,000
Q3 2023 Nov 03, 2023	SELL	$48.64 - $62.51 $448,655 - $576,592	-9,224 Reduced 86.47%	1,443 $80,000
Q2 2023 Aug 09, 2023	SELL	$47.99 - $60.21 $62,434 - $78,333	-1,301 Reduced 10.87%	10,667 $538,000
Q1 2023 May 09, 2023	SELL	$52.6 - $67.34 $212,714 - $272,322	-4,044 Reduced 25.26%	11,968 $652,000
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $67,481 - $86,787	-1,133 Reduced 6.61%	16,012 $1 Million
Q3 2022 Oct 27, 2022	BUY	$57.96 - $78.12 $219,784 - $296,231	3,792 Added 28.4%	17,145 $1.21 Million
Q2 2022 Aug 01, 2022	BUY	$39.5 - $64.42 $428,377 - $698,634	10,845 Added 432.42%	13,353 $757,000
Q1 2022 May 11, 2022	BUY	$43.74 - $62.76 $14,740 - $21,150	337 Added 15.52%	2,508 $157,000
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $4,550 - $6,674	91 Added 4.38%	2,171 $121,000
Q3 2021 Nov 10, 2021	BUY	$59.21 - $78.66 $14,684 - $19,507	248 Added 13.54%	2,080 $135,000
Q2 2021 Aug 05, 2021	BUY	$51.39 - $66.9 $42,807 - $55,727	833 Added 83.38%	1,832 $116,000
Q1 2021 Apr 28, 2021	BUY	$49.14 - $59.89 $12,972 - $15,810	264 Added 35.92%	999 $60,000
Q4 2020 Feb 04, 2021	BUY	$42.19 - $51.5 $15,990 - $19,518	379 Added 106.46%	735 $37,000
Q3 2020 Nov 10, 2020	BUY	$35.33 - $51.04 $10,493 - $15,158	297 Added 503.39%	356 $18,000
Q2 2020 Aug 07, 2020	BUY	$22.91 - $39.83 $1,351 - $2,349	59 New	59 $2,000
Q1 2020 May 13, 2020	SELL	$16.44 - $37.73 $16,440 - $37,730	-1,000 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$26.92 - $42.41 $26,920 - $42,410	1,000 New	1,000 $27,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account